Growth Metrics

Genoil (GNOLF) Common Equity (2018 - 2025)

Genoil has reported Common Equity over the past 8 years, most recently at -$538229.0 for Q3 2025.

  • Quarterly Common Equity fell 265.47% to -$538229.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$538229.0 through Sep 2025, down 265.47% year-over-year, with the annual reading at -$324875.0 for FY2024, 140.08% down from the prior year.
  • Common Equity was -$538229.0 for Q3 2025 at Genoil, down from -$453610.0 in the prior quarter.
  • Over five years, Common Equity peaked at $4381.0 in Q3 2023 and troughed at -$11.4 million in Q2 2023.
  • The 5-year median for Common Equity is -$7.0 million (2021), against an average of -$5.0 million.
  • Year-over-year, Common Equity skyrocketed 100.05% in 2023 and then tumbled 3461.61% in 2024.
  • A 5-year view of Common Equity shows it stood at -$9.0 million in 2021, then decreased by 21.56% to -$11.0 million in 2022, then soared by 98.77% to -$135320.0 in 2023, then crashed by 140.08% to -$324875.0 in 2024, then tumbled by 65.67% to -$538229.0 in 2025.
  • Per Business Quant, the three most recent readings for GNOLF's Common Equity are -$538229.0 (Q3 2025), -$453610.0 (Q2 2025), and -$396367.0 (Q1 2025).